Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
13,436
-11.24%
|
$994,264
$74.92 P/Share
|
|
Sep 16
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,436
+10.1%
|
$456,824
$34.03 P/Share
|
|
Sep 13
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,969
-20.26%
|
$1,995,706
$74.9 P/Share
|
|
Sep 13
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,969
+16.85%
|
$916,946
$34.03 P/Share
|
|
Sep 13
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
27,871
-15.71%
|
$2,062,454
$74.46 P/Share
|
|
Sep 13
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+6.81%
|
$154,000
$22.76 P/Share
|
|
Sep 12
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
635
-0.59%
|
$46,990
$74.92 P/Share
|
|
Sep 12
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
635
+0.59%
|
$21,590
$34.03 P/Share
|
|
Sep 10
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
37,575
-14.53%
|
$2,667,825
$71.63 P/Share
|
|
Sep 10
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,575
+21.44%
|
$375,750
$10.85 P/Share
|
|
Sep 06
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
149,002
-24.45%
|
$10,579,142
$71.65 P/Share
|
|
Sep 06
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
149,002
+11.49%
|
$3,278,044
$22.72 P/Share
|
|
Aug 29
2024
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
10,000
+36.08%
|
-
|
|
Aug 29
2024
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
10,000
-3.24%
|
-
|
|
Aug 12
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
9,469
-8.64%
|
$681,768
$72.49 P/Share
|
|
Aug 12
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
88,070
-28.49%
|
$6,429,110
$73.2 P/Share
|
|
Aug 12
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
88,070
+16.52%
|
$1,409,120
$16.05 P/Share
|
|
Jul 08
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
730
-0.82%
|
$51,100
$70.05 P/Share
|
|
Jun 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,195
-16.65%
|
$1,271,700
$60.0 P/Share
|
|
Jun 10
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,195
+14.27%
|
$487,485
$23.75 P/Share
|
|
Jun 03
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
55,000
-33.59%
|
$3,025,000
$55.33 P/Share
|
|
Jun 03
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+15.11%
|
$1,045,000
$19.42 P/Share
|
|
May 30
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
21,195
-16.65%
|
$1,165,725
$55.0 P/Share
|
|
May 30
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,195
+14.27%
|
$487,485
$23.75 P/Share
|
|
May 29
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
220,564
-65.25%
|
$11,028,200
$50.0 P/Share
|
|
May 29
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
220,564
+12.2%
|
$5,734,664
$26.26 P/Share
|
|
May 28
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
44,722
-33.49%
|
$2,191,378
$49.53 P/Share
|
|
May 28
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,971
+6.12%
|
$506,623
$13.63 P/Share
|
|
May 28
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,852
-3.09%
|
$384,748
$49.48 P/Share
|
|
May 28
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+4.66%
|
$75,000
$12.58 P/Share
|
|
May 28
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
20,724
-5.78%
|
$1,036,200
$50.01 P/Share
|
|
May 28
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,724
+1.57%
|
$538,824
$26.26 P/Share
|
|
May 28
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
103,806
-49.45%
|
$5,086,494
$49.62 P/Share
|
|
May 28
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
103,806
+33.09%
|
$2,387,538
$23.66 P/Share
|
|
May 28
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
27,500
-20.18%
|
$1,347,500
$49.53 P/Share
|
|
May 28
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+16.79%
|
$330,000
$12.58 P/Share
|
|
May 17
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,945
-3.83%
|
$148,625
$25.09 P/Share
|
|
May 17
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,642
-4.19%
|
$116,050
$25.09 P/Share
|
|
May 14
2024
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,093
-5.11%
|
$127,325
$25.4 P/Share
|
|
May 14
2024
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,088
-3.96%
|
$127,200
$25.47 P/Share
|
|
May 14
2024
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,857
-4.82%
|
$196,425
$25.5 P/Share
|
|
May 14
2024
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,088
-8.62%
|
$277,200
$25.32 P/Share
|
|
May 14
2024
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,640
-8.76%
|
$266,000
$25.47 P/Share
|
|
May 14
2024
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
22,198
-5.46%
|
$554,950
$25.52 P/Share
|
|
May 14
2024
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
6,508
-5.65%
|
$162,700
$25.53 P/Share
|
|
May 13
2024
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,308
+11.78%
|
-
|
|
May 13
2024
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.16%
|
-
|
|
May 13
2024
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+8.17%
|
-
|
|
May 13
2024
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.15%
|
-
|
|
May 13
2024
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,518
+10.68%
|
-
|